Davis, M., Alexander, K. M., Ambardekar, A., Judge, D. P., Mooney, D. M., Bolognese, L., … Maurer, M. S. (2025). ACORAMIDIS IMPROVES SERUM TTR LEVELS IN PATIENTS WITH WILD-TYPE OR VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 85, pp. 1663–1663).

Davis, Margot, Kevin Michael Alexander, Amrut Ambardekar, Daniel P. Judge, Deirdre Marie Mooney, Leonardo Bolognese, Michel Georges Khouri, et al. “ACORAMIDIS IMPROVES SERUM TTR LEVELS IN PATIENTS WITH WILD-TYPE OR VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 85:1663–1663, 2025.

Davis M, Alexander KM, Ambardekar A, Judge DP, Mooney DM, Bolognese L, et al. ACORAMIDIS IMPROVES SERUM TTR LEVELS IN PATIENTS WITH WILD-TYPE OR VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025. p. 1663–1663.

Davis, Margot, et al. “ACORAMIDIS IMPROVES SERUM TTR LEVELS IN PATIENTS WITH WILD-TYPE OR VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 85, no. 12, 2025, pp. 1663–1663.

Davis M, Alexander KM, Ambardekar A, Judge DP, Mooney DM, Bolognese L, Khouri MG, Cheng RK-H, Wright RF, Gordon RA, Du J, Siddhanti S, Tamby JF, Fox JC, Ji A, Sinha U, Gilmore JD, Maurer MS. ACORAMIDIS IMPROVES SERUM TTR LEVELS IN PATIENTS WITH WILD-TYPE OR VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025. p. 1663–1663.